BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Central America Standard Time BEGIN:STANDARD DTSTART;VALUE=DATE:20230101 TZNAME:Central America Standard Time TZOFFSETFROM:-0600 TZOFFSETTO:-0600 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Speaker:\nLisa H. Lancaster\, MD \;\nMedical Director\, Int erstitial Lung Disease Program \;\nProfessor of Medicine \;\nDivis ion of Allergy\, Pulmonary and Critical Care Medicine \;\nVanderbilt U niversity Medical Center \;\nNashville\, TN \;\nLearning Objective s\nUpon completion of this activity\, participants should be able to:\n\n Differentiate idiopathic pulmonary fibrosis (IPF) from other common ILD s\, such as connective tissue disease-associated ILD (CTD-ILD)\, accuratel y and efficiently using recommended clinical evaluation\, radiologic testi ng\, and pathologic testing as needed\n Apply evidence informing the us e of antifibrotic therapy\, nonpharmacologic strategies\, and management o f risk factors and comorbidities in patients with IPF to formulate treatme nt plans\n Individualize treatment of IPF based on patient characterist ics and preferences\, using shared decision-making\n\nRegister Today\nThis activity is provided by \;Paradigm Medical Communications\, LLC.\nHel d in collaboration with the Pulmonary Fibrosis Foundation. DTEND:20210622T164500Z DTSTAMP:20240329T054651Z DTSTART:20210622T154500Z LOCATION:Virtual SEQUENCE:0 SUMMARY:TEAM IPF: Thorough Evaluation and Appropriate Management of Idiopa thic Pulmonary Fibrosis UID:RFCALITEM638472700118167452 X-ALT-DESC;FMTTYPE=text/html:
Speaker:
\nLisa H. Lanc
aster\, MD \;
\nMedical Director\, Interstitial Lung Disease Progra
m \;
\nProfessor of Medicine \;
\nDivision of Allergy\, Pulm
onary and Critical Care Medicine \;
\nVanderbilt University Medical
Center \;
\nNashville\, TN \;
Learning Objecti
ves
\nUpon completion of this activity\, participants should b
e able to:
This activity is provided by&nbs
p\;Paradigm Medical Communications\, LLC.
\nHeld in collaboration with
the Pulmonary Fibrosis Foundation.